EQS-News: Mutares completes the acquisition of Synthomer a.s. from Synthomer plc to grow further the Chemicals & Materials segment
Mutares SE & Co. KGaA (MUX) has completed the acquisition of Synthomer a.s. from Synthomer plc, a European producer of acrylic solutions, for EUR 110 million in 2025 revenues. The deal strengthens Mutares' Chemicals & Materials segment, aligning with its strategy of acquiring businesses with improvement potential.
How this was made
The 30-second read
Why it matters
The transaction expands Mutares' chemicals platform while allowing Synthomer plc to streamline its portfolio. Market participants will assess integration synergies and cash deployment.
Market read
A primary M&A disclosure affecting two listed chemicals companies, with modest but actionable implications for their stocks.
What to watch
Potential regulatory approvals in the EU and the strategic use of sale proceeds for Synthomer plc.
Background
Mutares SE & Co. KGaA, a listed private‑equity holding on the Frankfurt Stock Exchange (SDAX), announced the completion of its carve‑out acquisition of Synthomer a.s., a European acrylic solutions producer.
Ticker impact
Mutares SE & Co. KGaA completed the acquisition of Synthomer a.s., adding a €110 m revenue platform to its Chemicals & Materials segment.
potential modest upside as market prices in growth potential
Acquisition adds a revenue-generating unit and aligns with Mutares' strategy; investors may view it as value‑creation.
Market effects
Adds scale to the European chemicals sector, potentially prompting re‑rating of peers.
May influence German SDAX constituents and UK chemical stocks.
Limited to specialty chemicals; no broad market effect.
Counterpoint
The acquisition could strain Mutares' balance sheet if integration costs exceed expectations.
Key entities
- companyMutares SE & Co. KGaA
Listed private‑equity holding (ticker MUX) completing an acquisition.
- companySynthomer plc
UK‑listed chemicals group (ticker SYNT.L) selling its subsidiary.
